Novartis AG (LTS:0K9E)
$ 104.7 0 (0%) Market Cap: 209.81 Bil Enterprise Value: 227.95 Bil PE Ratio: 12.53 PB Ratio: 5.07 GF Score: 80/100

Novartis AG - Sandoz Capital Markets Day (UK) Transcript

Jun 12, 2023 / 08:00AM GMT
Release Date Price: $93.39 (-0.80%)
Samir Shah
Novartis AG - Global Head of IR

Great. Can everybody hear? So good morning, everybody. Thank you so much for making your way here to the London Stock Exchange for our Capital Markets Day for Sandoz, and thank you to the people who are listening on the web, too. I apologize for some of the conditions here. It's rather warm in here so do feel free to take off your jackets and things if you need to, and we're trying to fix the air conditioning here.

So a great pleasure to have the whole Sandoz team here with us, and we'll be getting on with the program very shortly. Just a word or two. This slide, which is Slide 4, for the people on the web, goes through the agenda itself. And we've actually divided the day up into 4 sessions. The first session after I finish will be with Gilbert Ghostine, the Chairman-Designate; and Richard, the Chief Executive Officer for Sandoz. We're going to actually be talking then about business strategy, the investment proposal, et cetera. Following that, in the second session, we'll be talking about the commercial aspects of Sandoz, and we'll have the 3 business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot